Data Availability StatementFor new items or new indications approved in both the European Union and the USA after 1 January, 2014, Merck KGaA will share patient- and study-level data after deidentification, as well while redacted study protocols and clinical study reports from clinical tests in individuals

Data Availability StatementFor new items or new indications approved in both the European Union and the USA after 1 January, 2014, Merck KGaA will share patien...